This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their ...

In a German clinic, a climber undergoes pre-acclimatisation treatment ... high-altitude conditions in advance, the theory ...

A group of mountaineers plan to travel from Heathrow to the summit of Mount Everest and back in just seven days - a feat ...

A guiding service offers a pricey drug therapy (that's also illegal in professional sports) to get clients to the Everest ...

Akebia has since engaged with the FDA on potentially expanding vadadustat treatment to this patient population and has received feedback on a protocol submitted for a Phase 3 cardiovascular outcome ...

This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their ...

However, clinical treatment trials have so far been negative ... more information regarding temporal changes in, and origin of, erythropoietin levels. Our primary hypothesis was that high acute serum ...

That represents an uptick of 15% over the previous year's high of $17.3 billion ... 5–hydroxytryptamine 4 receptor agonist for the treatment of Alzheimer's disease. Biotech companies have ...

Objective To evaluate the efficacy and safety of intramuscular ultra-high-dose methylcobalamin ... may be more efficacious when treatment is started at an early stage of ALS. A recent clinical trial ...

In patients with cystic renal diseases (in whom mild or no anemia with elevated erythropoietin levels can occur), however, interstitial cells have been shown to express erythropoietin messenger ...

At presentation, he had a hemoglobin level of 220 g/l, a serum erythropoietin level of 27.4 U/l and a serum creatinine level of 200.7 µmol/l (2.27 mg/dl). Investigations: Physical examination ...